Ovarian Cancer Trial, By Invitation NCT03544983 Sponsor: Georgetown University Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, By Invitation

NCT03544983
By Invitation Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a close biological relative of someone who has recently been found to carry a BRCA1 or BRCA2 gene mutation — this means you are either a direct sibling or adult child of that person, or an aunt, uncle, niece, or nephew (if the parent who carries the mutation has passed away)

Who may not be able to join:

  • You have personally been diagnosed with cancer that has spread to other parts of your body (metastatic cancer)
  • You have already had genetic testing to check for hereditary breast or ovarian cancer risk
  • You have one or more children who have already tested positive for a BRCA1 or BRCA2 gene mutation
  • You are not able to participate in or understand English
  • You are not able to give informed consent, meaning you are not able to fully understand and agree to take part in the study on your own

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Georgetown University
Registry
ClinicalTrials.gov
Start date
1 May 2020
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Uptake of genetic counseling and testing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov